See every side of every news story
Published loading...Updated

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years - Regeneron Pharmaceuticals (NASDAQ:REGN)

Summary by defenseworld.net
Blueprint Medicines, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Gilead Sciences, D-Wave Quantum, and Johnson & Johnson are the seven Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are equity shares of companies that research, develop, manufacture and market prescription drugs, vaccines and other medical treatments. Their performance is driven by factors such as …

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Tuesday, June 3, 2025.
Sources are mostly out of (0)